Amedisys Inc
NASDAQ:AMED
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
89.45
98.45
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Amedisys Inc
Amedisys Inc
Cash & Cash Equivalents
Amedisys Inc
Cash & Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Amedisys Inc
NASDAQ:AMED
|
Cash & Cash Equivalents
$245.5m
|
CAGR 3-Years
25%
|
CAGR 5-Years
64%
|
CAGR 10-Years
46%
|
|
|
DaVita Inc
NYSE:DVA
|
Cash & Cash Equivalents
$1.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-3%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Cash & Cash Equivalents
$764m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
16%
|
|
|
CVS Health Corp
NYSE:CVS
|
Cash & Cash Equivalents
$6.9B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
20%
|
|
|
Cigna Corp
NYSE:CI
|
Cash & Cash Equivalents
$5.9B
|
CAGR 3-Years
19%
|
CAGR 5-Years
5%
|
CAGR 10-Years
14%
|
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Cash & Cash Equivalents
$1.5B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
33%
|
CAGR 10-Years
10%
|
|
Amedisys Inc
Glance View
Amedisys, Inc. engages in the provision of healthcare services. The company is headquartered in Baton Rouge, Louisiana and currently employs 21,000 full-time employees. The firm operates through four segments: Home Health, Hospice, Personal Care and high acuity care. The Home Health segment delivers a range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with important personal tasks. The Hospice segment provides palliative care and comfort to terminally ill patients and their families. The Personal Care segment provides patients with assistance with the essential activities of daily living. Its high acuity care segment delivers the essential elements of inpatient hospital and skilled nursing facility (SNF) care to patients in their homes. The firm owns and operates approximately 530 care centers in 38 states.
See Also
What is Amedisys Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
245.5m
USD
Based on the financial report for Sep 30, 2024, Amedisys Inc's Cash & Cash Equivalents amounts to 245.5m USD.
What is Amedisys Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
46%
Over the last year, the Cash & Cash Equivalents growth was 214%. The average annual Cash & Cash Equivalents growth rates for Amedisys Inc have been 25% over the past three years , 64% over the past five years , and 46% over the past ten years .
You don't have any saved screeners yet
